Introduction
Protein kinases constitute an important class of regulatory mechanisms of many cellular processes. Comparisons of the amino acid sequences of these enzymes have revealed that they possess characteristic conserved short motifs, some of which are known to be essential for enzyme activity (Hanks et al., 1988) . Protein kinase activities associated with animal viruses have been studied for many years, but it was only with extensive viral genomic sequencing that virus-encoded kinases were definitely identified. In the completely sequenced genome of herpes simplex virus type 1 (HSV-1) two genes (US3 and UL13) have been proposed to encode protein kinases on the basis of amino acid sequence motifs (McGeoch et al., 1988; McGeoch & Davison, 1986; Chee et al., 1989) , and it has also been suggested that the N-terminal domain of the larger subunit of HSV ribonucleotide reductase (encoded by gene UL39) might have kinase activity (Cheng et al., 1989; Paradis et al., 1991) .
The HSV-1 US3 protein kinase has been identified as an enzyme present in the cytoplasm of infected cells, and in virions (Purves et al., 1986; Frame et al., 1987; Zhang et al., 1990) . US3-defective mutants have been isolated, and it has been reported that although inactivation of the gene has little effect on virus growth in tissue culture, US3-defective virus is markedly impaired for growth in murine brain (Longnecker & Roizman, 1987; Meignier et al., 1988) . The US3 protein kinase has been purified, and it has been demonstrated that the enzyme phosphorylates a virion protein encoded by gene UL34 (Purves et al., 1986, I99I) . The physiological role of the US3 kinase remains obscure. Less work has been reported on the UL13 gene product. Cunningham et al. (1992) identified the UL 13 protein as a virion component, and correlated it with a novel protein kinase activity present in nuclei of infected cells. The US3 gene has homologues in other members of the alphaherpesvirus subfamily (van Zijl et at., 1990) but not in the beta-and gammaherpesvirus lineages, whereas the UL13 gene has counterparts in alpha-, beta-and gammaherpesviruses (see McGeoch, 1989) .
In this paper we report construction of a mutant of HSV-1 in which gene UL13 has been disrupted by insertion of Escherichia coli lacZ sequences, and a first analysis of the properties of the mutant. DNAs. s~P-labelled viral DNA was cut with BgllI (lanes 1 and 2) or XbaI (lanes 3 and 4) and separated on a 0.8 % or a 0.6 % agarose gel, respectively. Lanes 1 and 3, wt HSV-1 ; lanes 2 and 4, UL13-lacZ virus. The names of the wt fragments are to the left of lanes 1 and 3. Empty arrowheads (<~) indicate wt fragments which are lost in the UL13-taeZ virus, and filled arrowheads (,q) indicate the presence of novel fragments.
10 % foetal calf serum (FCS). Veto cells were grown in Eagle's medium supplemented with 10 % FCS. BHK-21 cells carrying the HSV-1 UL13 gene were grown in Eagle's medium containing 10% tryptose phosphate and 5% newborn calf serum and supplemented with 800 lag/ml Geneticin G-418 sulphate (Gibco).
Virus. The wild-type virus used in these experiments was a stock grown from a single plaque of the parental HSV-1 strain 17 syn ÷ (Brown et aL, 1973) .
Construction of HSV-1 mutant with gene UL13 inactivated, pFJ3 (Rixon & McLauchlan, 1990) contains the lacZ gene of E. coli under the control of the simian virus (SV40) early promoter, present in a 4.1 kbp XbaI fragment.
A plasmid containing a disrupted UL13 open reading frame (ORF) was obtained as follows. Plasmid pGX125 (Davison & Wilkie, 1983) , which contains the KpnI f fragment of HSV-1, was partially digested with XhoI to give a fragment of 2'2 kbp (HSV-1 genomic residues 26 347 to 28 555) which contains the UL13 ORF (28 504 to 26 950). This fragment was subcloned into the Sail site of pAT153 to give plasmid pLC1. Plasmid pLC2 was then constructed by cutting pLC1 at the single XhoI site, within the UL13 ORF, blunt-ending and inserting an XbaI linker. Finally, the XbaI fragment of pFJ3 was inserted into the XbaI site of pLC2 to give pLC3.
HSV-1 DNA (0-4 lag) was mixed with linearized pLC3 (0.1 lag to 5 lag, an approximate 2.5-fold to 125-fold molar excess over the HSV-1 DNA) in the presence of 6 lag of calf thymus DNA as carrier, and transfected into BHK-21 cells. The cotransfection was carried out by calcium phosphate precipitation followed by a DMSO boost, as described by Stow & Wilkie (1976) . Cells were incubated at 37 °C in the presence of Eagle's medium supplemented with 5 % (v/v) newborn calf serum until c.p.e, was extensive. The cells were scraped into the medium, subjected to ultrasonic disruption and virus was titrated under CM-cellulose. When plaques were observed the CM-cellulose overlay was replaced with CM-cellulose containing 1 mM-X-Gal, a chromogenic substrate for fl-galactosidase. Resultant blue plaques were picked, carried through five rounds of plaque purification and stocks were grown after analysis with restriction enzymes.
Cell lines expressing HSV-1 gene UL13. Plasmids for construction of UL13-expressing cell lines were made as follows. UL13 sequences were recovered from plasmid pTZUL13(Xho) (Cunningham et al., 1992) by digestion with BamHI and PstI, and cloned into pIC20R (Marsh et al., 1984) . The ULI3 sequence was then recovered as a BgllI/BamHI fragment and cloned into the BgllI site of the expression vector pKSV-10 (Pharmacia) downstream of the SV40 early promoter. Plasmids containing UL 13 in either the sense or antisense orientation relative to this promoter were recovered, and for each a neomycin resistance gene was inserted as a BamHI fragment into the BamHI site of pKSV-10, giving plasmids p394 (UL13 sense orientation) and p395 (antisense).
Each plasmid was transfected into BHK-21 cells with calf thymus carrier DNA by calcium phosphate precipitation. Seventeen hours later Geneticin G-418 sulphate was added to 800 lag/mt. In each case drugresistant colonies grew out, and were pooled.
Restriction enzyme analysis of 32p-labelled virus DNA. Restriction enzyme analysis of the virus isolates was based on the method of Lonsdale (1979) . Cells were infected at a multiplicity of 10, in phosphate-free Eagle's medium and labelled with 10 laCi/ml 3~p. After incubation at 37 °C for 48 h, DNA was extracted using SDS and phenol followed by ethanol precipitation. The DNA pellet was resuspended in buffer containing RNase A (11 units/ml) and RNase T1 (22 units/ml) and digested with 1 to 2 units of the appropriate restriction enzyme under the conditions specified by the manufacturer. The restriction fragments generated were separated on 0'6 % or 0-8 % agarose gels. Gels were dried and exposed to X-Omat XS-1 film.
Purification of virions.
Virions were purified essentially as described by Szilfigyi & Cunningham (1991) . Briefly, monolayers of BHK-21 cells in 80 oz plastic roller bottles were infected at an m.o.i, of 0.01 and incubated at 31 °C until c.p.e, was widespread (4 to 5 days), and virus was pelleted from the clarified medium by centrifugation. The pellet was resuspended in Eagle's medium without phenol red and centrifuged through a 5 to 15 % Ficoll gradient. The virions appeared as a well defined lower band, and the light (L) particles (which consist of tegument and envelope structures but lack capsids) formed a more diffuse upper band. Virions and L particles were withdrawn separately from the gradient, pelleted and resuspended in the modified Eagle's medium.
Detergent treatment of virions. Purified virions were treated with detergent before assaying for protein kinase activity. To virion preparations, Tris-HC1 pH 7.5, magnesium chloride and DTT were added to concentrations of 10 m~, 1 mM and 1 mM respectively. NP40 was then added to a concentration of 0.05 % and the virions were left on ice for 1 h. An equal volume of 10 mM-Tris-HC1 pH 7.5, 1 mMmagnesium chloride and 1 mM-DTT was then added to reduce the NP40 concentration to 0.025 %.
Purified virions were stripped to release envelope proteins by the addition of NP40 in Eagle's medium without phenol red to a final concentration of 1%. After 20 min on ice, the virions were pelleted and resuspended in Eagle's medium without phenol red in a volume equal to that of the supernatant. Denaturing buffer ( x 3) (Marsden et al., 1976) was added to samples which were heated at 100 °C for 5 min and electrophoresed in an SDS-containing 7-5 % gel cross-linked with 1:40 (w/w) N,N'-methylenebisacrylamide.
Preparation of nuclear extracts. BHK-21 ceils were either mockinfected or infected with wt HSV-1 or ULl3-1acZ at an m.o.i, of 10 to 20 in Eagle's medium containing newborn calf serum. Before infection of BHK-21 cells that carried the UL13 gene (394 and 395 cells), the cells were passaged in the absence of Geneticin G-418 sulphate, which was also omitted during infection. Crude nuclear extracts were prepared by removing medium from mock-infected or infected cells in 50 mm Petri dishes, rinsing the cell sheets in PBS and centrifuging the cells at 800 g for 5 rain. The cells were washed once in PBS and the pellet was resuspended in 250 gl buffer A (10 mM-HEPES pH 8, 50 mM-NaC1, 0.5 w-sucrose, 1 m~-EDTA, 0.5% Triton X-100, 1 mM-PMSF, 7 mM-2-mercaptoethanol). Each sample was hand-homogenized and then centrifuged at 900 g for 10 min. The supernatant was discarded. The nuclear pellet was rinsed twice in buffer A and drained thoroughly before being resuspended in 250 ~1 buffer A.
Phosphorylation in vitro. Nuclear extracts were incubated for 40 min at 37 °C in a final volume of 20 gl containing 50mM-Tris-HC1 pH 7.5, 10 mM-magnesium chloride, 1 mM-DTT and 1 gCi [7-~P]ATP (Amersham). NaC1 was added to each assay as described in the figure legends. Phosphorylated species were examined by electrophoresis in SDS-9 % polyacrylamide followed by antoradiography of the dried gel.
Staining of proteins in gels.
Silver staining of SDS-polyacrylamide gels was carried out as described by McLean et aL (1990) and staining with Coomassie blue was as described by Marsden et al. (1976) .
Results

Isolation of an HSV-1 mutant with the UL13 gene disrupted
An HSV-1 strain 17 mutant with the E. coli lacZ gene inserted in the UL13 ORF was obtained by homologous recombination between wt HSV-1 and a plasmid-borne disrupted UL13 ORF. The plasmid pLC3 was prepared, carrying lacZ inserted in the UL13 ORF, so that the ORF was disrupted just upstream of the sequence encoding the proposed protein kinase catalytic domain Chee et al., 1989) . pLC3 DNA was linearized and cotransfected into BHK-21 cells with HSV-1 DNA, and progeny virus expressing the lacZ gene purified by plaquing in the presence of X-gal. One isolate was chosen for further study and was designated UL 13-1acZ. The genome structure of UL13-lacZ was examined by digestion of 32P-labelled virus DNA with XbaI or BglII followed by gel electrophoresis. As shown in Fig. 1 , the mutant lacked the wt XbaI c (34 kbp) fragment, within which UL13 lies, and instead contained three novel fragments, which represent the two parts of XbaI c (17'4 and 16.5 kbp) and the lacZ insert (4-1 kbp). In wt HSV-1 the UL13 gene lies within the BglII o fragment. The insertion of the lacZ gene introduced a novel BglII site resulting in the replacement of the o fragment (5-3 kbp) with a fragment of 6.7 kbp and one of 2.7 kbp (Fig. 1) . These analyses thus demonstrate that the lacZ DNA was located in the UL13 ORF as intended and that no other large sequence alterations had occurred.
Detection of UL13 gene product in virions
The silver-stained polypeptide profiles of purified virions and L particles of HSV-1 wt and UL13-lacZ were compared. In both virion and L particle preparations a prominent band of approximate M r 57K was present for wt but not for UL13-1acZ. The size of this band is in close agreement with that determined by Cunningham et al. (1992) for the UL13 gene product and we therefore conclude that this virion species represents the UL13 gene product. Thus the UL13 protein is now found to be a readily detected stainable component of wt virions.
The location of the UL13 protein in virions was examined by treatment of virions with detergent followed by centrifugation to separate capsid plus tegument components (in the pellet) from envelope-associated proteins (in the supernatant). As shown in Fig. 2(b) , in wt virions the 57K species was found in the pellet (lane 1) and not in the supernatant, and in UL13-1acZ virions was absent from both fractions (lanes 3 and 4) . Since the 57K species is not one of the components of the well defined and relatively simple capsid, this experiment indicates that it must be resident in the tegument. The presence of 57K in L particles, which lack capsids, is also consistent with a tegument location (Fig. 2a) . The fractionation also demonstrates that the diffuse band of glycoprotein D (in the supernatant after detergent treatment) overlaps the 57K band. The 57K band was also visible in Coomassie blue-stained gels of wt virions, although it appeared less prominent than with silver staining (Fig. 3 c) .
The UL13 protein is probably equivalent to a previously described virion protein termed VP18.8, based on mapping assignment and comparison with published gel electrophoretic data (Lemaster & Roizman, 1980; Costa et al., t983; Braun et al., 1984) .
Growth properties of UL13-1acZ
The plaque morphology of UL13-lacZ in BHK-21 cells differed from that of wt in that UL13-1acZ plaques were smaller (about half the diameter of wt) and their borders were more distinct. The pattern of growth of UL13-IacZ was compared with that ofwt HSV-1 in BHK-21 cells at 37 °C, following infection at an m.o.i, of 0.001 (Fig. 3) . The growth of UL13-lacZ was only slightly impaired compared to wt. A similar small impairment with UL13 lacZ was observed when cells were infected at an m.o.i, of 10 and harvested over a period of 24 h (not shown). Growth in HFL and Vero cells gave comparable results (not shown). UL13-1acZ did not display any differential temperature sensitivity relative to wt in growth in BHK-21 cells (not shown). Determination of particle/p.f.u, ratios for UL13-1acZ and wt gave indistinguishable ranges of values (not shown).
Protein phosphorylation in infected cell extracts and virions
Protein phosphorylation was examined in nuclear extracts of virus-infected cells and in detergent-treated virions, by incubation with [~-a2P]ATP followed by fractionation by SDS-PAGE and autoradiography. Fig.  4 shows the a2P-tabelled polypeptide profiles following in vitro phosphorylation in nuclear extracts at a range of NaC1 concentrations. In HSV-1 wt cell extracts, a strongly labelled band of apparent M r 57K was present at all salt concentrations. This prominent phosphoprotein was shown by Cunningham et al. (1992) to be the UL13 gene product. Another strongly phosphorylated band of M r 38K was seen which also increased in intensity with increasing salt concentration. In UL13-lacZ extracts, the phosphorylated 57K UL13 protein was absent, and there was a reduction in the degree of phosphorylation of several proteins including the 38K protein. Fig. 5 shows the in vitro phosphorylated polypeptide profiles obtained with disrupted virions over a range of salt concentrations. A number of comparably labelled bands were observed. Concentrating on the 57K and 38K bands in wt virions, the labelling of 57K increased in intensity with increasing salt concentration and the 38K band was strongly phosphorylated throughout the range of salt concentrations. In UL13-1acZ virions, the 57K phosphoprotein was absent and the 38K band was present under low salt conditions but decreased in intensity as the salt concentration increased.
We interpret these data as follows. First, the absence of phosphorylated 57K from UL13-lacZ virions and nuclei is consistent with this species representing the UL13 gene product. Second, the UL13 protein is involved in phosphorylation of the 38K species, particularly at high salt concentrations. The simplest interpretation is that the UL13 kinase catalyses 38K phosphorylation at a high salt concentration; however, some less direct mechanism is also possible. Two other species in the UL13-1acZ virions show decreasing labelling with increasing salt (from gel mobilities these are probably the immediate early 175K protein and glycoprotein B), and therefore these are also possible UL13 kinase substrates. Other kinase activities are evidently present in the UL13-lacZ virions, including one responsible for phosphorylating 38K at low salt.
Mapping of the gene encoding the 38K phosphorylated protein
We observed that in vitro phosphorylation of HSV-2-infected nuclear extracts gave an apparent equivalent of the HSV-1 38K protein which migrated faster in S D S -P A G E , with an estimated M r of 36K. The genomic location of the genes encoding the 38K and 36K proteins was analysed by examining the mobility of the phosphorylated bands (Fig. 6a) produced by a set of HSV-1-HSV-2 recombinants of known structure (Fig.   6 b) . The limits of mapping were defined by recombinant R13-4 to 0-64 to 0-70 m a p units (m.u.). This compares with a similar mapping (approximately 0.65 to 0"70 m.u.) reported by Marsden et al. (1978) for major HSV-1 and HSV-2 phosphoproteins (phosphate-labelled intracellularly), of 38K and 36K respectively. Recently, Elliott & Meredith (1992) have reported that the 38K/36K species is the major tegument phosphoprotein VP22 and that it is encoded by gene UL49 (0.69 to 0.70 m.u.). Therefore it seems very likely that the 38K species we have observed is VP22. As an aside, no labelled 57K band was produced by recombinant R12-5 (not shown), so the UL13 gene may be defective in this virus.
A cell line expressing UL13
A cell line derived from BHK-21 cells was isolated, which expressed the UL13 gene under the control of the SV40 early promoter, as outlined in Methods. The UL13- expressing cell line was designated 394, and a control line (with the UL13 ORF in the antisense orientation) was designated 395. Preliminary experiments showed that 394 cells produced UL13 mRNA (not shown), but gave no in vitro phosphorylated 57K band (Fig. 7) . U L 1 3 -l a c Z in BHK-21 cells and 395 cells yielded no labelled 57K band and only a faintly labelled 38K band (Fig. 7a) . In 394 cells UL13-1acZ gave a labelled 38K band and a labelled 57K band with an extra band running slightly slower. This latter species is UL13-related, resulting from an additional upstream initiation codon introduced during manipulation of the UL13 DNA fragment used in obtaining the 394 cell line (Cunningham et al., 1992) . We conclude that the UL13 protein expressed from the resident gene in the 394 cells was capable of being phosphorylated when the cells were infected with HSV and that the UL13 protein produced by the 394 cells was active in phosphorylating the 38K species, VP22. Purified UL13-1acZ virions grown in 394 cells were found to contain 57K which could be phosphorylated (plus the associated species characteristic of the 394 line) as shown in Fig. 7 (b) .
Discussion
The protein encoded by HSV-1 gene UL 13 was predicted, on the basis of characteristic sequence motifs, to be a protein kinase or other phosphotransferase Chee et al., 1989) . Cunningham et al. (1992) detected the UL13 protein in infected cell extracts and in virions, showed that it could be phosphorylated in vitro and gave circumstantial evidence that the protein does possess protein kinase activity.
In the present paper we describe the isolation and properties of an HSV-1 mutant in which the UL13 gene is disrupted by insertion of lacZ sequences. Staining of virion preparations of wt HSV-1 and UL 13-1acZ showed that the UL13 protein can be directly visualized in wt HSV-1, i.e. it is a significantly abundant structural protein. In wt virus the protein is located in the tegument. The UL13 protein probably corresponds to a previously noted species referred to as VP18.8.
UL 13-lacZ grew only slightly less well than wt in three cell lines. The UL13 gene is therefore dispensable for growth in tissue culture, as are many other HSV genes (see, for instance, McGeoch, 1989) . In a preliminary experiment to test the pathogenicity of U L 1 3 -l a c Z in mice, only a slightly increased LDs0 relative to wt was observed after intracranial inoculation (L. Robertson, L. J. Coulter & C. A. MacLean, unpublished data).
Assays of protein kinase activities in nuclear extracts of infected cells and in disrupted virion preparations were carried out by incubation with [7-32P]ATP followed by fractionation of labelled proteins. As expected, the prominently phosphorylated band of UL13 protein observed with wt virus (Cunningham et al., 1992) was absent from mutant preparations. The mutant also showed reduced phosphorylation of several proteins, most prominently a species of estimated Mr 38K. The gene encoding this latter protein was localized by analysis of HSV intertypic recombinants, and is almost certainly UL49, encoding the abundant tegument phosphoprotein VP22. Other kinases are active in disrupted virions, which could in principle include the US3 protein kinase and cellular protein kinases (Stevely et al., 1985) . In the absence of UL13-mediated phosphorylation of VP22 (38K) some labelling of this band (and o f certain higher M r bands) was observed at low salt concentration. Similar results were obtained with a US3-deficient mutant (L. J. Coulter & H. W. M. Moss, unpublished data). There is no information on whether VP22 is a physiological or important target for the UL13 kinase. A cell line expressing UL13 was constructed, initially because it was anticipated that gene UL13 might be essential for virus growth. N o phosphorylation of U L 13 protein was detectable in uninfected extracts o f the 394 cells. However, when extracts of the cells infected with U L 1 3 -l a c Z were examined, phosphorylated UL13 and VP22 proteins were observed. The basis of nonphosphorylation o f UL13 in uninfected 394 cells is presently obscure: it could represent an indirect effect, for instance UL13 protein m a y be unstable in the absence o f virion components, or perhaps UL13 phosphorylation is carried out by a kinase other than UL13 itself. The 394 cells also allowed preparation of virus which carried the UL13 gene product but was genetically U L 13-, which may be of use in analysis of the protein's role.
The UL13 gene belongs to the subset of herpesvirus genes for which homologues have been found in all sequenced genomes of mammalian herpesviruses, and it is therefore reasonable to suppose that it must play a significant role in herpesvirus infection. Our finding that the UL13 protein is a readily detected component of virions suggests that its presence in virions m a y be central to the protein's role. It could, for instance, act on entry to the newly infected cell, or it might alternatively have a role in a maturation process within nascent virions. We expect that our UL13-1acZ mutant will prove valuable in further investigation.
